| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 672140 | Null | 0.0401206532535666 | 0.30688175 |
| NSC 674103 | 2-Acetylimidazo[4,5-b]pyridin 4 p-chlorophenyl 3 thiosemicarbazone | 0.0401206532535666 | -0.094354804 |
| NSC 676532 | Ether-20 | 0.0401206532535666 | 0.17564192 |
| NSC 677369 | Null | 0.0401206532535666 | 0.18687042 |
| NSC 689626 | Null | 0.0401206532535666 | 0.17538152 |
| NSC 711077 | Null | 0.0401206532535666 | 0.21935845 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.0401206532535666 | 0.10571653 |
| NSC 724783 | [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 | 0.0401206532535666 | 0.16702832 |
| NSC 729166 | N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide | 0.0401206532535666 | 0.035253373 |
| NSC 741425 | 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide | 0.0401206532535666 | 0.21295778 |